Jul 23, 2014

CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy

CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular indications, starts its Phase IIa clinical trial for chronic heart failure (HF) patients with non-ischemic cardiomyopathy. READ FULL ARTICLE